EarningsQ2 2026 Earnings Report
MX:SUNN Q2 2026 EPS Results
Actual EPS$88.79
Consensus EPS$103.04
Beat/MissMissed by -$14.25
One Year Ago EPS$82.00
MX:SUNN Q2 2026 Revenue Results
Actual Revenue$36.67B
Expected Revenue$37.27B
Beat/MissMissed by -$601.16M
YoY Revenue Growth-4.09%
Earnings Announcement Details
QuarterQ2 2026
Date07/28/2026
TimeTBA
Conference CallTuesday, July 28, 2026
MX:SUNN Upcoming Earnings
Sulzer AG's next earnings date is estimated for February 24, 2027, based on past reporting schedules.
Q2 2026 Earnings Call Audio
MX:SUNN Q2 2026 Earnings Call
0:00 / 0:00
Q2 2026 Earnings Slide Deck
Q2 2026 Earnings Call Summary
Earnings Call Sentiment|Positive
The call presents a constructive operational and profitability story: strong margin expansion, Flow and Services regaining momentum, and clear execution of Sulzer Excellence and strategic initiatives. However, significant headwinds remain—primarily within Chemtech (large order delays in new technologies), elevated net working capital and free‑cash‑flow pressure, and geopolitical-related project timing risk. Management reiterated its full‑year guidance and expects orders to be back‑loaded into H2/Q4, indicating confidence but also execution risk tied to the timing of large awards.Company Guidance
Profitability Improvement
Group EBITDA margin increased to 15.5% in H1 (up ~110 basis points year-over-year compared with prior reporting), with higher absolute EBITDA and net income in CHF driven by better gross margins and Sulzer Excellence execution.
Flow Division Margin Momentum
Flow EBITDA margin reached 13.3% (from 8.7% in H1 2023) with a 100 basis point increase versus prior year; order intake recovered Q1 (-3.8%) to Q2 (+6.6%), showing regained momentum.
Services Growth and Margin Expansion
Services sales grew +4.4% in H1 (from a very high base in H1 2025) and its order intake gross margin improved by 140 basis points to 40.6%; Services EBITDA margin up ~100 basis points despite regional disruptions.
Book-to-Bill and Backlog Health
Book-to-bill ratios above 1.0 across business units (except new technologies in Chemtech), MTCS book-to-bill >1, and management reports a filling order pipeline with indications of large orders returning, expected back‑loaded into H2/Q4.
Sulzer Excellence Delivering Operational Gains
Multiple global initiatives improved on-time and in-spec delivery, commercial discipline (market-value pricing, order cycle reduction) and supply‑chain/design-to-cost actions, contributing materially to margin gains.
Confirmed Full-Year Guidance
Management reiterates 2026 guidance: order intake +1% to +5%, sales +2% to +5%, and full-year EBITDA margin ~16.5%.
FX and Currency Management
Currency effects reduced sales/orders by ~CHF 100 million (≈5% FX impact), but profitability gains and Excellence measures more than offset FX headwinds in CHF terms.
Innovation and New Solutions
Progress on advanced projects (e.g., subsea CO2 reinjection pumps with Petrobras/Technip; PEF polymer trials as a PET replacement) demonstrating technology differentiation and potential long-term opportunities.
MX:SUNN Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed